JPWO2022125566A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022125566A5
JPWO2022125566A5 JP2023534636A JP2023534636A JPWO2022125566A5 JP WO2022125566 A5 JPWO2022125566 A5 JP WO2022125566A5 JP 2023534636 A JP2023534636 A JP 2023534636A JP 2023534636 A JP2023534636 A JP 2023534636A JP WO2022125566 A5 JPWO2022125566 A5 JP WO2022125566A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
polypeptide
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023534636A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023552462A5 (https=
JP2023552462A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/062238 external-priority patent/WO2022125566A1/en
Publication of JP2023552462A publication Critical patent/JP2023552462A/ja
Publication of JP2023552462A5 publication Critical patent/JP2023552462A5/ja
Publication of JPWO2022125566A5 publication Critical patent/JPWO2022125566A5/ja
Pending legal-status Critical Current

Links

JP2023534636A 2020-12-08 2021-12-07 半減期延長組成物および方法 Pending JP2023552462A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063122818P 2020-12-08 2020-12-08
US63/122,818 2020-12-08
PCT/US2021/062238 WO2022125566A1 (en) 2020-12-08 2021-12-07 Half-life extending compositions and methods

Publications (3)

Publication Number Publication Date
JP2023552462A JP2023552462A (ja) 2023-12-15
JP2023552462A5 JP2023552462A5 (https=) 2024-12-12
JPWO2022125566A5 true JPWO2022125566A5 (https=) 2024-12-12

Family

ID=81973740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023534636A Pending JP2023552462A (ja) 2020-12-08 2021-12-07 半減期延長組成物および方法

Country Status (9)

Country Link
US (1) US20240034814A1 (https=)
EP (1) EP4259178A4 (https=)
JP (1) JP2023552462A (https=)
KR (1) KR20230156897A (https=)
CN (1) CN117042788A (https=)
AU (1) AU2021397734A1 (https=)
CA (1) CA3201560A1 (https=)
MX (1) MX2023006732A (https=)
WO (1) WO2022125566A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021287998B2 (en) 2020-06-11 2026-03-12 Benaroya Research Institute At Virginia Mason Methods and compositions for preventing type 1 diabetes
AU2021396172A1 (en) 2020-12-09 2023-07-06 Janux Therapeutics, Inc. Compositions and methods related to tumor activated antibodies targeting psma and effector cell antigens
US12565529B2 (en) 2021-05-24 2026-03-03 Provention Bio, Inc. Methods for treating type 1 diabetes
GB2641580A (en) 2024-06-07 2025-12-10 T Therapeutics Ltd Tumour-transforming multispecific proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1355919E (pt) * 2000-12-12 2011-03-02 Medimmune Llc Moléculas com semivida longa, composições que as contêm e suas utilizações
WO2004041867A2 (en) * 2002-11-08 2004-05-21 Ablynx N.V. Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
SG173488A1 (en) * 2009-02-19 2011-09-29 Glaxo Group Ltd Improved anti-serum albumin binding variants
CN111433224B (zh) * 2017-11-17 2024-03-19 南京传奇生物科技有限公司 抗pd-l1的单结构域抗体及其变体
WO2019204925A1 (en) * 2018-04-24 2019-10-31 National Research Council Of Canada Serum albumin binding antibodies for tuneable half-life extension of biologics
CN113508134B (zh) * 2019-02-22 2024-12-03 安维达生物科技公司 白蛋白结合抗体及其用途

Similar Documents

Publication Publication Date Title
JP2021020905A5 (https=)
JP2020114210A5 (https=)
JP2021159081A5 (https=)
CN115057936A (zh) 异源二聚体多特异性抗体形式
JP2020505919A5 (https=)
JP2023123649A5 (https=)
JP2024113040A5 (https=)
JP2026004299A5 (https=)
ME02653B (me) Genski proizvodi koji su diferencijalno izraženi u tumorima i njihova primjena
JPWO2021116182A5 (https=)
JP2025124718A5 (https=)
AR129202A1 (es) Anticuerpos activados por tumores que se dirigen a trop2 y usos de estos
JPWO2020247871A5 (https=)
JPWO2020011976A5 (https=)
JPWO2022094299A5 (https=)
JPWO2022035866A5 (https=)
JPWO2022125566A5 (https=)
IL322564A (en) Prostate-specific membrane antigen (PSMA)-targeting compositions and methods for their preparation and use
JPWO2021007260A5 (https=)
AU2019232759A1 (en) Anti-TIP-1 antibodies and uses thereof
WO2024061224A1 (zh) 抗her2抗体及其用途
JPWO2022129560A5 (https=)
JPWO2023068377A5 (https=)
JPWO2022190018A5 (https=)
WO2021256524A1 (ja) 免疫原性低減型低分子抗体とその製造法